Sionna Therapeutics (SION) Interest & Investment Income (2024 - 2026)

Sionna Therapeutics has disclosed Interest & Investment Income across 3 years of filings, most recently posting $2.8 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $2.8 million, down 6.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.1 million (up 30.65% YoY), and the FY2025 annual result was $13.3 million, up 62.73% from the prior year.
• Interest & Investment Income came in at $2.8 million for Q1 2026 at Sionna Therapeutics, down from $3.2 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $3.7 million in Q2 2025 to a low of $1.1 million in Q1 2024.
• The 3-year median for Interest & Investment Income is $2.8 million (2026), against an average of $2.7 million.
• Across the five-year window, Interest & Investment Income surged 165.02% in 2025 and decreased 6.0% in 2026, its largest moves.
• Sionna Therapeutics' Interest & Investment Income stood at $2.1 million in 2024, then soared by 49.69% to $3.2 million in 2025, then retreated by 11.1% to $2.8 million in 2026.
• The last three Interest & Investment Income figures came in at $2.8 million (Q1 2026), $3.2 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.